FdaApplication
ANDA 208600
Identifiers
- fda_app_no: ANDA208600
Properties
| Property | Value |
|---|---|
| applicant_name | AMPHASTAR PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-03-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENOXAPARIN SODIUM | ENOXAPARIN SODIUM | 300MG/3ML (100MG/ML) | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1 product